Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-World Study of Pyrrolitinib Maleate Tablets for HER-2-Positive Early or Locally Advanced Breast Cancer After Adjuvant Trastuzumab Therapy

NCT06470347 is registered in ClinicalTrials.gov with Zunyi Medical College as lead sponsor.

NCT NCT06470347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06470347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-World Study of Pyrrolitinib Maleate Tablets for HER-2-Positive Early or Locally Advanced Breast Cancer After Adjuvant Trastuzumab Therapy
Lead sponsor
Zunyi Medical College
Phase
Phase 1/2
Overall status
Unknown status
Start date
November 1, 2022
Completion date
November 1, 2025
Enrollment
67 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her-2 positive advanced breast cancer